Status
Conditions
Treatments
About
A sequential multiple-assignment randomized controlled trial (SMART) will be used to assess the effect of an adaptive stepped-care intervention on FCR in cancer survivors with subclinical levels of fear of cancer recurrence.
Full description
The current SMART trial aims to address the following hypotheses:
Hypothesis 1: It is better to begin adaptive interventions with eConquerFear than with eHealthMaintenance.
Hypothesis 2: Among initial non-respondents, it is better to switch to supervised, face-to-face ConquerFear than to augment eConquerFear with eHealthMaintenance.
Hypothesis 3: eConquerFear + ConquerFear will lead to the greatest reduction in fear of cancer recurrence.
Hypothesis 4: There would be an indirect effect of stepped-care ConquerFear intervention on fear of cancer recurrence through its effect on maladaptive metacognition and cognitive attentional syndrome.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
300 participants in 4 patient groups
Loading...
Central trial contact
Danielle Ng, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal